Sensitization to TNF-induced apoptosis by 1,25-dihydroxy vitamin D3 involves up-regulation of the TNF receptor 1 and cathepsin B

International Journal of Cancer

Volumn 93, Issue 2, 2001, Pages 224-231

  Mathiasen, Ida Stenfeldt ^a   Hansen, Christina Mørk ^a   Foghsgaard, Lasse ^b   Jäättelä, Marja ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b Leo Pharmaceutical Products ^*  (Denmark)

Author keywords

Apoptosis; Breast cancer; Cathepsin B; TNF; Vitamin D compound

Indexed keywords

CALCITRIOL; CASPASE; CATHEPSIN B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOLIPASE A2; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; BINDING SITE; BREAST CANCER; CELL DEATH; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LYSOSOME; PRIORITY JOURNAL; SENSITIZATION; SIGNAL TRANSDUCTION;

ANTIGENS, CD; APOPTOSIS; CASPASES; CATHEPSIN B; DRUG INTERACTIONS; ENZYME ACTIVATION; HUMANS; NF-KAPPA B; PHOSPHOLIPASES A; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; STEROID HYDROXYLASES; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0035879752     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1325     Document Type: Article

References (37)

1. 3 and vitamin D analogs
2. EB 1089: A new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro
3. EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells
4. Seocalcitol (EB 1089): A vitamin D analogue of anti-cancer potential. Background, design, synthesis, pre-clinical and clinical evaluation
5. 3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cells
6. 3 in androgen-responsive LNCaP cells
7. Leukemia cell differentiation: Cellular and molecular interactions of retinoids and vitamin D
8. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53
9. 3 analogue shows relation to promoter selectivity
10. 3 potentiates the cytotoxic effect of TNF on human breast cancer cells
11. 2
12. Modulation of life and death by the TNF receptor superfamily
13. Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed from the receptor
14. Molecular cloning and expression of a receptor for human tumor necrosis factor
15. Death receptors: Signaling and modulation
16. Tumor necrosis factor receptor and Fas signaling mechanisms
17. Activation of a pro-apoptotic amplification loop through inhibition of NF-κB-dependent survival signals by caspase-mediated inactivation of RIP
18. Control of apoptosis by Rel/NF-κB transcription factors
19. Apoptosis signaling by death receptors
20. 2 in tumor necrosis factor-induced apoptosis
21. Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c
22. Cathepsin B acts as a dominant execution protease in tumour cell apoptosis induced by death receptors
23. 2 in breast carcinoma cells
24. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assay
25. Negative regulation of immunoglobulin kappa light-chain gene transcription by a short sequence homologous to the murine B1 repetitive element
26. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
27. Tumor necrosis factor: Specific binding and internalization in sensitive and resistant cells
28. Role of caspases and NF-κB signaling in hydrogen peroxide- and superoxide-induced hepatocyte apoptosis
29. BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases
30. All-trans-retinoic acid up-regulates TNF receptors and potentiates TNF-induced activation of nuclear factors-κB, activated protein-1 and apoptosis in human lung cancer cells
31. 2 is crucial in the cytotoxic action of tumor necrosis factor
32. 2s in fatty acid release in the cell death pathway
33. 2 mediates lymphocyte proliferation
34. 3
35. 3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage
36. The vitamin D3 analog EB 1089 enhances the response of human breast tumor cells to radiation
37. 3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death